Chinthanie F. Ramasundarahettige

Hamilton, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 45 publications

Community-level infrastructure risk factors for motor vehicle injuries of car occupants and pedestrians: results from the PURE study.

Community-level infrastructure risk factors for motor vehicle injuries of car occupants and pedestrians: results from the PURE study.

Journal: International journal of injury control and safety promotion

Published: November 08, 2025

Complete versus culprit lesion-only revascularisation for acute myocardial infarction (Complete Revascularisation Trialists' Collaboration): an individual patient data meta-analysis of randomised trials.

Complete versus culprit lesion-only revascularisation for acute myocardial infarction (Complete Revascularisation Trialists' Collaboration): an individual patient data meta-analysis of randomised trials.

Journal: Lancet (London, England)

Published: September 21, 2025

Monitoring time-to-detection of recurrent atrial fibrillation in patients with transient new-onset atrial fibrillation detected initially during hospitalization for noncardiac surgery or medical illness.

Monitoring time-to-detection of recurrent atrial fibrillation in patients with transient new-onset atrial fibrillation detected initially during hospitalization for noncardiac surgery or medical illness.

Journal: European journal of internal medicine

Published: June 25, 2025

Atrial fibrillation progression in patients with device-detected subclinical atrial fibrillation: Insights from the ARTESiA trial.

Atrial fibrillation progression in patients with device-detected subclinical atrial fibrillation: Insights from the ARTESiA trial.

Journal: Heart rhythm

Published: May 29, 2025

Apixaban for stroke prevention in subclinical atrial fibrillation detected by an implantable cardiac monitor: A subgroup analysis of ARTESiA.

Apixaban for stroke prevention in subclinical atrial fibrillation detected by an implantable cardiac monitor: A subgroup analysis of ARTESiA.

Journal: Heart rhythm

Published: May 10, 2025

Virtual physiological analysis of non-culprit disease in patients with STEMI and multivessel disease: a substudy of the COMPLETE trial.

Virtual physiological analysis of non-culprit disease in patients with STEMI and multivessel disease: a substudy of the COMPLETE trial.

Journal: European heart journal open

Published: March 03, 2025

Benzodiazepine-Free Cardiac Anesthesia for Reduction of Postoperative Delirium: A Cluster Randomized Crossover Trial.

Benzodiazepine-Free Cardiac Anesthesia for Reduction of Postoperative Delirium: A Cluster Randomized Crossover Trial.

Journal: JAMA surgery

Published: January 29, 2025

Frailty Assessment for Risk prediction in Gynecologic Oncology patients undergoing surgery and chemotherapy (FARGO) study protocol: Rationale and design of a multi-centre prospective cohort study.

Frailty Assessment for Risk prediction in Gynecologic Oncology patients undergoing surgery and chemotherapy (FARGO) study protocol: Rationale and design of a multi-centre prospective cohort study.

Journal: PloS one

Published: January 06, 2025

Comparison of total event analysis and first event analysis in relation to heterogeneity in cardiovascular trials.

Comparison of total event analysis and first event analysis in relation to heterogeneity in cardiovascular trials.

Journal: BMC medical research methodology

Published: December 06, 2024

Secondary Prevention Medications in 17 Countries Grouped by Income Level (PURE): A Prospective Cohort Study.

Secondary Prevention Medications in 17 Countries Grouped by Income Level (PURE): A Prospective Cohort Study.

Journal: Journal of the American College of Cardiology

Published: September 03, 2024

Impact of baseline FIB-4 score on efpeglenatide benefits on cardiovascular outcomes in people with type 2 diabetes: a participant-level exploratory analysis of the AMPLITUDE-O trial.

Impact of baseline FIB-4 score on efpeglenatide benefits on cardiovascular outcomes in people with type 2 diabetes: a participant-level exploratory analysis of the AMPLITUDE-O trial.

Journal: Cardiovascular diabetology

Published: July 30, 2024

Apixaban vs Aspirin According to CHA2DS2-VASc Score in Subclinical Atrial Fibrillation: Insights From ARTESiA.

Apixaban vs Aspirin According to CHA2DS2-VASc Score in Subclinical Atrial Fibrillation: Insights From ARTESiA.

Journal: Journal of the American College of Cardiology

Published: April 12, 2024

Showing 1-12 of 45

Last Updated: 09/26/2026